Skip to content


Abstract submission for COSMEDICON 2021 closes Saturday, 31 October 2020

Abstract submissions will be accepted for the scientific program at Cosmedicon 2020. To view the guidelines and download the abstract template, click on the links below. Guidelines for abstracts are also listed at the end of this page.

The scientific committee will be responsible for reviewing submitted abstracts and responses will be sent in mid-November 2019.

Important Dates

  • Open Abstract Submissions: 01 August 2020
  • Abstract submission closes: 31 October 2020

Abstracts are encouraged from, but not restricted to the following topic areas: 

  • Products and techniques for facial enhancement
  • Facial rejuvenation techniques
  • Cosmeceuticals
  • Dermatological issues
  • Body shaping techniques 
  • Intense Pulsed Light (IPL)
  • Laser for vascular / pigmented lesions
  • Laser theory and safety
  • Fractionated laser technology
  • Medico-legal issues
  • Photorejuvenation techniques
  • Pre and post treatment care
  • Stem cells, supplements and anti-ageing medicines
  • Strategies to optimise your cosmetic practice

COSMEDICON 2021 Abstract Submission Instructions 

Please submit abstracts using the prescribed template. If submitting more than one abstract, please use a separate template.

Abstract title: The title should be short, informative and contain the major key words.

Authors’ names: The format commences with the authors’ surname followed by first initial, with the presenting author underlined. Superscript numbers must be used to indicate the author’s institution. Do not include degrees or professional titles (eg: Dr, Prof etc).

Authors’ organisations/institutions: Please include the name, city, state and country (in this order) of the organizations/institutions and appropriate superscript numbers.

Abstract text: Format single-spaced and justified. Abstracts are to be a maximum of 300 words, including references. There is to be a maximum of 2 references. Use standard abbreviations only within the body of the abstract.

Abstract should address:

  1. Background and aim(s)
  2. Method
  3. Result(s)
  4. Conclusion(s)

When using abbreviations spell out the name in full at the first mention and follow with the abbreviation in parenthesis. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract. Capitalise the first letter of trade names.

Care should be taken to ensure high quality English expression and grammar.

Contents should include the following sections:

Background and Aims: Include one or two sentences to introduce the broad topic area and provide a reason for the study. Provide a clear statement of the aims of the study. A hypothesis could be included in this section. It may also be appropriate to add references to cited literature here. References will be included in the word limit. Authors are advised to keep references to a minimum, and to use an abbreviated referencing system, i.e. First author et al., no title, year of publication, abbreviated journal title, volume, pages.

Methods: In this section information on participants (and /or subjects) should be provided. This may include the number of participants, demographic information such as age and gender as well as the method of recruitment. (ie a random sample or a convenient sample). Study inclusion and exclusion criteria should be included in this section as well as a sample size calculation if presenting a randomised clinical trial. Measures and procedures used in the study are described in this section. Descriptions of analyses appear in the methods section.

Results: The purpose of the result section is to provide a description of the main findings of the study. Reference to potential results that were unavailable at the time that the abstract was submitted will not be acceptable. Submitted abstracts must include actual results. Results should be expressed as means or medians and the spread of the results indicated as ranges, standard deviations or 95% confidence intervals as appropriate. Probability values must be included, but are not sufficient of themselves without descriptive statistics (means, etc).

Conclusions: In this section you should provide statements of interpretation and implication of findings, as well as comparison with previous literature. It should not be a simple restatement of the results.

Contact Cosmedicon 2021

Use the details below or the contact form to the right to get in touch.

Michelle Kearney +61 (0)419 624 246



Contact Us

Phone: +61 (0)2 8095 6265

Michelle Kearney
Mobile: 0419 624 246

Bill Dunk
Mobile: 0410 528 582

Bella Media
Suite 2201, Westfield Tower 2
101 Grafton St
Bondi Junction NSW 2022 Australia


ABN: 86 082 157 695

Disclaimer/Privacy Policy